Individualization of Dosage Regimen
An Approach Towards Improved Clinical Outcomes
Introduction
The scope of designing dose regimens has increased with the application of therapeutic drug monitoring for drugs like antibiotics. Pharmacokinetic parameters show the relationship between dose, plasma concentration, and clinical factors. Individualized dosing aims to stay within the therapeutic window, balancing benefit and toxicity.
Dosage Regimen Definition
The dosage regimen is the schedule of medication administration, including time between doses, duration of treatment, and amount per dose. It also includes the formulation, route, dosing interval, and treatment length.
Clinical Implications
While preapproved regimens are used for average patients, individualization is innovative and important for improved treatment outcomes. Adaptation based on individual characteristics (weight, age, comorbidities) is necessary, especially in conditions like renal or liver impairment.
Importance of Dosage Regimen
- Designs dose and frequency for specific treatments.
- Determines Minimum Effective Concentration (MEC) and Minimum Toxic Concentration (MTC).
- Helps establish doses for narrow therapeutic index drugs.
- Therapeutic drug monitoring ensures beneficial effects with proper oversight.
- Multiple dosing regimens are used for prolonged therapeutic activity.
Objectives
- Maintain plasma concentration within narrow therapeutic limits for chronic diseases.
- Achieve exact plasma levels without accumulation or variation outside the therapeutic window.
- Achieve required MEC for antimicrobials and similar drugs.
- Define MEC and MTC for drugs like digoxin with narrow therapeutic index.
- Optimize multiple administration to keep plasma concentration within the therapeutic window.
Factors Affecting Dose Regimen
Age
Pediatric patients have immature hepatic and renal function, leading to drug accumulation and toxicity. Geriatric patients have reduced clearance, increasing toxicity risk.
Body Weight
Standard doses are for 70 kg individuals. Dosage adjustment is needed for underweight or overweight patients.
Body Surface Area (BSA)
Many physiological processes correlate with BSA, making it a useful dosing parameter.
Sex
Women may be more susceptible to certain drugs. Pregnancy and lactation require special caution due to drug transfer to fetus or infant.
Pathological State
Disease states alter drug effects and require dose adjustment. Cautionary labels guide prescribers.
Tolerance
Developed with continued use (e.g., antihistamines, opioids). Minimized by starting with lowest effective dose and avoiding prolonged use.
Drug-Drug Interactions
Effects altered by simultaneous administration due to chemical interaction or changes in ADME.
Designing Dosage Regimen & Superposition
Pharmacokinetic parameters are assumed constant once regimen is established. Calculations often use one-compartment models.
Design from Plasma Concentration
If volume of distribution (Vd) and half-life are known, regimen can be designed to maintain therapeutic concentration.
Parameters for Dosage Regimen
| Parameter | Description | Impact |
|---|---|---|
| Dose Size | Amount given per administration | Directly affects therapeutic/toxic response; larger doses increase fluctuation and toxicity risk. |
| Dosing Frequency | Time interval between doses | Affects plasma fluctuation and accumulation; must be balanced with dose size. |
Dose Frequency Scenarios
- Higher frequency (< T1/2): Lesser fluctuation, therapeutic response, but higher toxicity risk.
- Optimum frequency (= T1/2): Good therapeutic response.
- Lower frequency (> T1/2): Larger fluctuations, poor therapeutic response.
Note: For wide therapeutic index drugs (e.g., penicillin), larger doses at longer intervals are acceptable. For narrow index drugs (e.g., digoxin), small frequent doses minimize fluctuation.
Therapeutic Drug Monitoring (TDM)
TDM measures drug concentrations in biological fluids and interprets them using pharmacokinetic data, sampling time, drug history, and clinical condition.
Why Perform TDM?
- Individualizing therapy
- Diagnosing and avoiding toxicity
- Monitoring changing clinical states
- Detecting drug interactions
- Managing narrow therapeutic index drugs
- Handling pharmacokinetic variability
- When plasma concentration correlates with clinical effects
- Cost-effective drug assays available
Individualization via TDM
Before regimen design, consider:
- Sample timing relative to last dose
- Achievement of steady state
- Patient adherence
- Drug-drug interactions
- Renal or liver dysfunction
- Linear kinetics assessment
Plasma Drug Concentration after Multiple Dosing
Repeated administration leads to accumulation until steady state is reached, where elimination rate equals administration rate. Plasma concentration fluctuates between doses.
Factors Affecting Steady State
- Dose administration rate: Directly proportional to steady state concentration.
- Bioavailability: Affects rate of dose administration.
- Clearance: Inversely related to steady state concentration.
Factors Affecting Fluctuation
- Frequency of administration: Inverse relation with plasma fluctuation.
- Elimination half-life: Inverse relation with fluctuation.
- Rate of absorption: Slower absorption reduces fluctuation.
Equations for Assessment
Where Ï„ = dosing interval, F = bioavailability, CL = clearance.
Where λ = elimination rate constant = CL / Vd.
Where C1 = concentration after first dose.
Accumulation to Steady State
Time to steady state depends on elimination half-life. Example: Phenobarbital (t1/2 = 100 h) with daily dosing.
Multiple Dosage Regimen in Chronic Diseases
Used for conditions like arthritis and hypertension to maintain plasma concentration within therapeutic range. Examples: cardiotonics, antihypertensives, anticonvulsants.
Superposition Principle
Early doses do not affect pharmacokinetics of later doses. Plasma concentrations after subsequent doses superimpose on previous levels.
Conclusion
The main goal is maximum therapeutic response with minimal toxicity. Individualization based on patient-specific factors and therapeutic drug monitoring allows precise regimen design, improving clinical outcomes and safety.
